Inventor · disambiguated record
Naganari Ohkura
Also filed as: OHKURA NAGANARI
3 granted patents·6 pending applications·11 citations·filing 2018–2022
62Inventor score
Top patents by PatentIndex Score
9 records- 0191US10550191B2Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8SHIONOGI & CO·Filed 2018·Granted Feb 4, 2020·10 cites·28 claims
- 0283US11932696B2Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cellsSHIONOGI & CO·Filed 2020·Granted Mar 19, 2024·1 cites·7 claims
- 0366US2021047421A1Pharmaceutical Composition for Cancer TreatmentSHIONOGI & CO·Filed 2020·Application pending·0 cites
- 0464US2020232973A1Pharmaceutical Composition for Cancer TreatmentSHIONOGI & CO·Filed 2020·Application pending·0 cites
- 0564US2020222463A1Pharmaceutical Composition for Cancer TreatmentSHIONOGI & CO·Filed 2020·Application pending·0 cites
- 0656US2023111840A1Compound, And Method For Producing Regulatory T CellsUNIV KYOTO·Filed 2022·Application pending·0 cites
- 0753US11578067B2Compound, and method for producing regulatory T cellsUNIV KYOTO·Filed 2018·Granted Feb 14, 2023·0 cites·14 claims
- 0852US2024190975A1Chimeric antigen receptor that recognizes ccr8 as antigenSHIONOGI & CO·Filed 2022·Application pending·0 cites
- 0947US2022064312A1Novel Anti-CCR8 AntibodySHIONOGI & CO·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naganari Ohkura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →